Brunden K R, Poduslo J F
J Cell Biol. 1987 Mar;104(3):661-9. doi: 10.1083/jcb.104.3.661.
The major myelin protein, P0, has been shown to have decreased levels of expression and altered oligosaccharide processing after the disruption of Schwann cell-axon interaction. We show here that lysosomal degradation of the glycoprotein shortly after its synthesis accounts for much of its decreased expression in the permanently transected adult rat sciatic nerve, a denervated preparation where there is no axonal regeneration or myelin assembly. If [3H]mannose incorporation into sciatic nerve endoneurial slices is examined in the presence of the lysosomotropic agent, NH4Cl, a marked increase in the level of newly synthesized P0 is seen. Pulse-chase analysis of [3H]mannose-labeled P0 in the presence of NH4Cl indicates that this increase is a consequence of inhibition of P0 degradation that normally occurs 1-2 h after biosynthesis in the transected nerve. P0 degradation can also be inhibited if lysosomal function is disturbed by dilation of secondary lysosomes with L-methionine methyl ester. The addition of deoxymannonojirimycin or swainsonine (SW), inhibitors of oligosaccharide-processing mannosidases I and II, respectively, also results in a decrease in P0 degradation. This inhibition is presumably caused by a blockage of transport to the lysosomes due to altered processing of the glycoprotein, although the direct inhibition of lysosomal mannosidases cannot be excluded. In contrast to the transected nerve, addition of NH4Cl or SW has no effect on P0 levels in the crushed nerve, where myelin assembly occurs. The delivery of P0 to the lysosomes of the transected nerve Schwann cells does not appear to be triggered by the mannose-6-phosphate transport system involved in acid hydrolase routing. The accumulation of a fucosylated species of P0 in the presence of SW indicates that the glycoprotein has progressed at least as far as the site of GlcNAc transferase I without lysosomal delivery, and thus differs from the typical mannose-6-phosphate-containing glycoproteins. Furthermore, there is no evidence of P0 phosphorylation either in the absence or presence of NH4Cl or SW. These findings indicate that the amount of P0 in the transected nerve is regulated at the posttranslational level as well as at the level of transcription.
主要髓鞘蛋白P0已被证明,在施万细胞 - 轴突相互作用中断后,其表达水平降低且寡糖加工发生改变。我们在此表明,糖蛋白在合成后不久即被溶酶体降解,这在很大程度上解释了其在成年大鼠坐骨神经永久横断后表达降低的现象,在这种去神经支配的标本中不存在轴突再生或髓鞘组装。如果在存在溶酶体促渗剂NH4Cl的情况下检测[3H]甘露糖掺入坐骨神经内膜切片的情况,会发现新合成的P0水平显著增加。在NH4Cl存在下对[3H]甘露糖标记的P0进行脉冲追踪分析表明,这种增加是由于抑制了P0的降解,而P0降解通常在横断神经的生物合成后1 - 2小时发生。如果用L - 蛋氨酸甲酯使次级溶酶体扩张从而干扰溶酶体功能,P0降解也可被抑制。分别添加去氧甘露糖野霉素或苦马豆素(SW),即寡糖加工甘露糖苷酶I和II的抑制剂,也会导致P0降解减少。这种抑制大概是由于糖蛋白加工改变导致向溶酶体的转运受阻引起的,尽管不能排除对溶酶体甘露糖苷酶有直接抑制作用。与横断神经不同,添加NH4Cl或SW对发生髓鞘组装的挤压神经中的P0水平没有影响。横断神经施万细胞的溶酶体向P0的递送似乎不是由参与酸性水解酶转运的甘露糖 - 6 - 磷酸转运系统触发的。在SW存在下P0的岩藻糖基化物种的积累表明,该糖蛋白至少已经进展到了N - 乙酰葡糖胺转移酶I的位点而没有被递送至溶酶体,因此不同于典型含甘露糖 - 6 - 磷酸的糖蛋白。此外,无论是否存在NH4Cl或SW,都没有P0磷酸化的证据。这些发现表明,横断神经中P0的量在翻译后水平以及转录水平都受到调控。